Entecavir and Episcleritis - a phase IV clinical study of FDA data

Summary:

Episcleritis is reported as a side effect among people who take Entecavir (entecavir), especially for people who are male, 40-49 old,.

The phase IV clinical study analyzes which people have Episcleritis when taking Entecavir. It is created by eHealthMe based on reports of 7,338 people who have side effects when taking Entecavir from the FDA, and is updated regularly.

What is Entecavir?

Entecavir has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 7,354 Entecavir users. Check the latest studies of Entecavir.

What is Episcleritis?

Episcleritis (acute inflammatory disorder of the episclera of eye) is found to be associated with 129 drugs and 182 conditions by eHealthMe. Check the latest studies of Episcleritis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

7,338 people reported to have side effects when taking Entecavir.
Among them, 14 people (0.19%) have Episcleritis.

Among these 14 people:

What is the gender of people who have Episcleritis when taking Entecavir? *

female: 0.0 %
male: 100 %

What is the age of people who have Episcleritis when taking Entecavir? *

What are other side effects people have besides Episcleritis? *

Testicular Atrophy (wasting of testes): 14 people, 100.00%
Enlarged Prostate: 14 people, 100.00%
Pneumonia Influenzal (the flu with pneumonia): 13 people, 92.86%
Osteoporosis (bones weak and more likely to break): 12 people, 85.71%
Hepatic Enzyme Increased: 12 people, 85.71%
Disease Recurrence: 11 people, 78.57%
Vasculitis (inflammation of a blood vessel or blood vessels): 9 people, 64.29%

* Approximation only. Some reports may have incomplete information.

Do you take Entecavir and have Episcleritis?

- Check whether Episcleritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Entecavir:

Entecavir (7,354 reports)

Episcleritis treatments and more:

Episcleritis (969 reports)

Browse all side effects of Entecavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Episcleritis:

Episcleritis (129 drugs)

Browse all the conditions that are associated with Episcleritis:

Episcleritis (182 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on entecavir (the active ingredients of Entecavir) and Entecavir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.